VCRE
Vicore Pharma Holding AB
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$11.59
+0.35%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.05
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 21, 2026
- EPS actual
- -$0.05
- EPS estimate
- -$0.04
- Revenue actual
- $226.6K
- Revenue estimate
- $59.1K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -24.4%
- Revenue beats (12Q)
- 1
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026